PubMed

Links between transforming growth factor-beta and canonical Wnt signaling yield new insights into breast cancer susceptibility, suppression and tumor heterogeneity.

Incassati A, Pinderhughes A, Eelkema R, Cowin P.

Breast Cancer Res. 2009;11(3):103. Epub 2009 May 20.PMID: 19519951 [PubMed - indexed for MEDLINE]Related articlesFree article

The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways.

Lei S, Dubeykovskiy A, Chakladar A, Wojtukiewicz L, Wang TC.

J Biol Chem. 2004 Oct 8;279(41):42492-502. Epub 2004 Jul 28.PMID: 15292219 [PubMed - indexed for MEDLINE]Related articlesFree article

Redundant expression of canonical Wnt ligands in human breast cancer cell lines.

Benhaj K, Akcali KC, Ozturk M.

Oncol Rep. 2006 Mar;15(3):701-7.PMID: 16465433 [PubMed - indexed for MEDLINE]Related articles

Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis.

Labbé E, Lock L, Letamendia A, Gorska AE, Gryfe R, Gallinger S, Moses HL, Attisano L.

Cancer Res. 2007 Jan 1;67(1):75-84.PMID: 17210685 [PubMed - indexed for MEDLINE]Related articlesFree article

Cross-talk between Wnt and bone morphogenetic protein 2 (BMP-2) signaling in differentiation pathway of C2C12 myoblasts.

Nakashima A, Katagiri T, Tamura M.

J Biol Chem. 2005 Nov 11;280(45):37660-8. Epub 2005 Sep 2.PMID: 16150699 [PubMed - indexed for MEDLINE]Related articlesFree article

Loss of TGF-beta or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotype.

Roarty K, Baxley SE, Crowley MR, Frost AR, Serra R.

Breast Cancer Res. 2009;11(2):R19. Epub 2009 Apr 3.PMID: 19344510 [PubMed - indexed for MEDLINE]Related articlesFree article

A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.

Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM, Birchmeier W.

Gastroenterology. 2009 Jul;137(1):165-75. Epub 2009 Mar 26.PMID: 19328798 [PubMed - indexed for MEDLINE]Related articles

Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.

Schlange T, Matsuda Y, Lienhard S, Huber A, Hynes NE.

Breast Cancer Res. 2007;9(5):R63.PMID: 17897439 [PubMed - indexed for MEDLINE]Related articlesFree article

Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.

Urakami S, Shiina H, Enokida H, Kawakami T, Tokizane T, Ogishima T, Tanaka Y, Li LC, Ribeiro-Filho LA, Terashima M, Kikuno N, Adachi H, Yoneda T, Kishi H, Shigeno K, Konety BR, Igawa M, Dahiya R.

Clin Cancer Res. 2006 Jan 15;12(2):383-91.PMID: 16428476 [PubMed - indexed for MEDLINE]Related articlesFree article

Wnt5a is required for proper mammary gland development and TGF-beta-mediated inhibition of ductal growth.

Roarty K, Serra R.

Development. 2007 Nov;134(21):3929-39. Epub 2007 Sep 26.PMID: 17898001 [PubMed - indexed for MEDLINE]Related articlesFree article

p130Cas is required for mammary tumor growth and transforming growth factor-beta-mediated metastasis through regulation of Smad2/3 activity.

Wendt MK, Smith JA, Schiemann WP.

J Biol Chem. 2009 Dec 4;284(49):34145-56. Epub 2009 Oct 12.PMID: 19822523 [PubMed - indexed for MEDLINE]Related articles

Beta-catenin/LEF-1 signalling in breast cancer--central players activated by a plethora of inputs.

Gebeshuber CA, Sladecek S, Grunert S.

Cells Tissues Organs. 2007;185(1-3):51-60. Review.PMID: 17587808 [PubMed - indexed for MEDLINE]Related articles

Prostate tumor progression is mediated by a paracrine TGF-beta/Wnt3a signaling axis.

Li X, Placencio V, Iturregui JM, Uwamariya C, Sharif-Afshar AR, Koyama T, Hayward SW, Bhowmick NA.

Oncogene. 2008 Nov 27;27(56):7118-30. Epub 2008 Aug 25.PMID: 18724388 [PubMed - indexed for MEDLINE]Related articles

Wnt signaling pathway in invasive ductal carcinoma of the breast: relationship between beta-catenin, dishevelled and cyclin D1 expression.

Prasad CP, Gupta SD, Rath G, Ralhan R.

Oncology. 2007;73(1-2):112-7. Epub 2008 Mar 13.PMID: 18337623 [PubMed - indexed for MEDLINE]Related articles

Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer.

Bierie B, Chung CH, Parker JS, Stover DG, Cheng N, Chytil A, Aakre M, Shyr Y, Moses HL.

J Clin Invest. 2009 Jun;119(6):1571-82. doi: 10.1172/JCI37480. Epub 2009 May 18.PMID: 19451693 [PubMed - indexed for MEDLINE]Related articlesFree article

Methylation-associated silencing of SFRP1 with an 8p11-12 amplification inhibits canonical and non-canonical WNT pathways in breast cancers.

Yang ZQ, Liu G, Bollig-Fischer A, Haddad R, Tarca AL, Ethier SP.

Int J Cancer. 2009 Oct 1;125(7):1613-21.PMID: 19569235 [PubMed - indexed for MEDLINE]Related articles

Wnt-5a-CKI{alpha} signaling promotes {beta}-catenin/E-cadherin complex formation and intercellular adhesion in human breast epithelial cells.

Medrek C, Landberg G, Andersson T, Leandersson K.

J Biol Chem. 2009 Apr 17;284(16):10968-79. Epub 2009 Feb 25.PMID: 19244247 [PubMed - indexed for MEDLINE]Related articles

Transforming growth factor-beta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein kinase and Wnt signaling cross-talk.

Tuli R, Tuli S, Nandi S, Huang X, Manner PA, Hozack WJ, Danielson KG, Hall DJ, Tuan RS.

J Biol Chem. 2003 Oct 17;278(42):41227-36. Epub 2003 Jul 31.PMID: 12893825 [PubMed - indexed for MEDLINE]Related articlesFree article

WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer.

Ying J, Li H, Yu J, Ng KM, Poon FF, Wong SC, Chan AT, Sung JJ, Tao Q.

Clin Cancer Res. 2008 Jan 1;14(1):55-61.PMID: 18172252 [PubMed - indexed for MEDLINE]Related articlesFree article

X-linked inhibitor of apoptosis protein and its E3 ligase activity promote transforming growth factor-{beta}-mediated nuclear factor-{kappa}B activation during breast cancer progression.

Neil JR, Tian M, Schiemann WP.

J Biol Chem. 2009 Aug 7;284(32):21209-17. Epub 2009 Jun 15.PMID: 19531477 [PubMed - indexed for MEDLINE]Related articles